EMA Authorised: Ovaleap (follitropin alfa) — Theramex Ireland Limited

View source ↗

Summary

EMA authorised Ovaleap (follitropin alfa) for the treatment of anovulation. The marketing authorisation holder is Theramex Ireland Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation
• Infertility

Drugs mentioned

• Ovaleap (follitropin alfa)

Snippet

Status: Authorised. Therapeutic area: Anovulation. MAH: Theramex Ireland Limited. Decision date: 16/04/2025